Cardiopulmonary exercise testing with supramaximal verification produces a safe and valid assessment of V̇o2max in people with cystic fibrosis: a retrospective analysis
- PMID: 30346240
- DOI: 10.1152/japplphysiol.00454.2018
Cardiopulmonary exercise testing with supramaximal verification produces a safe and valid assessment of V̇o2max in people with cystic fibrosis: a retrospective analysis
Abstract
The validity and safety of using supramaximal verification (Smax) to confirm a maximal effort during cardiopulmonary exercise testing (CPET) in people with cystic fibrosis (CF) and/or those with severe disease has been questioned. Therefore, this study aimed to investigate these concerns in children, adolescents, and adults with mild-to-severe CF lung disease. Retrospective analysis of 17 pediatric and 28 adult participants with CF [age range: 9.2-62.9 y; forced expiratory volume in 1 s: 66.7% (range: 29.9%-102.3%); 30 men] who completed a routine ramp-incremental cycling test to determine peak oxygen uptake (V̇o2peak) was studied. Maximal oxygen uptake (V̇o2max) was subsequently confirmed by Smax at 110% of peak power output. All participants satisfied the criteria to verify a maximal effort during CPET. However, Smax-V̇o2peak exceeded ramp-V̇o2peak in 3/14 (21.4%) of pediatric and 6/28 (21.4%) adult exercise tests. A valid measurement of V̇o2max was attained in 85.7% of pediatric and 96.4% of adult exercise tests, as Smax-V̇o2peak did not exceed ramp-V̇o2peak by >9%. Adults ( n = 9) experienced a ≥5% reduction in arterial O2 saturation during CPET, 4 during both the ramp and Smax, 3 during only the ramp, and 2 during only Smax. Smax did not significantly worsen perceived breathing effort, chest tightness, throat narrowing, or exertion compared with ramp-incremental testing. Given the clinical importance of aerobic fitness in people with CF, incorporating Smax is recommended to provide a safe and valid measure of V̇o2max in children, adolescents, and adults who span the spectrum of CF disease severity. NEW & NOTEWORTHY Incorporating supramaximal verification into cardiopulmonary exercise testing protocols did not increase the frequency of adverse events or perceived discomfort versus a single-phase incremental exercise test in people with mild-to-severe cystic fibrosis. Furthermore, a valid measure of maximal oxygen uptake (V̇o2max) was obtained from 85.7% of pediatric and 96.4% of adult exercise tests, whereas peak oxygen uptake underestimated aerobic fitness in comparison with V̇o2max in 21.4% of cases (by up to 24.4%).
Keywords: cardiorespiratory fitness; maximal oxygen uptake; peak oxygen uptake; respiratory disease.
Comment in
-
Supramax exercise testing in cystic fibrosis: not ready for prime time.J Appl Physiol (1985). 2019 Jan 1;126(1):264. doi: 10.1152/japplphysiol.00782.2018. J Appl Physiol (1985). 2019. PMID: 30694710 Free PMC article. No abstract available.
-
Reply to Cooper.J Appl Physiol (1985). 2019 Jan 1;126(1):265. doi: 10.1152/japplphysiol.00839.2018. J Appl Physiol (1985). 2019. PMID: 30694712 No abstract available.
-
Confirming V̇o2max without bias.J Appl Physiol (1985). 2019 Feb 1;126(2):511. doi: 10.1152/japplphysiol.00883.2018. J Appl Physiol (1985). 2019. PMID: 30799674 No abstract available.
-
Reply to Askew and Green.J Appl Physiol (1985). 2019 Feb 1;126(2):512. doi: 10.1152/japplphysiol.00939.2018. J Appl Physiol (1985). 2019. PMID: 30799675 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
